TAG:
clinical testing
Washington State’s PacLab Network Is A Regional Winner
By Robert Michel | From the Volume V No. 14 – October 19, 1998 Issue
CEO SUMMARY: As a regional laboratory network, PacLab is unusual in one respect: participating hospital laboratories did not meet endlessly to talk about what they should do. Instead, action was the operative word for these network organizers. Since becoming operational in 1996, their bia…
Nichols Institute Earns ISO 9001 Certification
By Robert Michel | From the Volume V No. 9 – July 6, 1998 Issue
CEO SUMMARY: Although it’s the first ISO 9001-certified clinical laboratory in North America, Quest Diagnostics’ Nichols Institute is a late-comer to the party. Most major diagnostics companies already have ISO 9001 certification. This issue of THE DARK REPORT explores why Nichols’ …
Substance Abuse Testing Gains Increasing Favor
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
CEO SUMMARY: Here’s an update to our earlier predictions that clinical laboratories would find substance abuse testing to be a profitable adjunct to clinical testing. Evidence accumulates that competition in the drugs of abuse marketplace is intensifying. While still a relatively small …
Unilab & LabOne Demonstrate Improved Revenues and Profits
By Robert Michel | From the Volume V No. 7 – May 26, 1998 Issue
AFTER AN EXTENDED MULTI-YEAR financial siege, Unilab Corporation seems to be regaining its balance. First quarter financials demonstrate respectable gains in revenue and net income at the California based laboratory. Big gains were posted by LabOne, Inc. of Lenexa, …
UroCor, Inc.; Histology & AP.
By Robert Michel | From the Volume IV No. 17 – December 8, 1997 Issue
UROCOR, INC. MATCHES THERAPEUTICS WITH DIAGNOSTICS With the recent signing of a co-promotion agreement with Zeneca Pharmaceuticals, UroCor, Inc. is positioned to offer therapeutics as a complement to its diagnostic testing. Based in Oklahoma City, UroCor is a fast-growing c…
Niche Markets Boost Earnings For Both DIANON And LabOne
By Robert Michel | From the Volume IV No. 16 – November 17, 1997 Issue
THIRD QUARTER EARNINGS at DIANON Systems and LabOne, Inc. demonstrate that niche market strategies can be growth engines for clinical laboratories, even in the face of declining reimbursement. As the crunch in clinical testing hit the laboratory industry in recent y…
Lab Industry Briefs
By Robert Michel | From the Volume IV No. 12 – August 25, 1997 Issue
MONOLAYER PAP SMEAR TEST In travels to laboratories around the United States, THE DARK REPORT is getting interesting, but anecdotal, feedback about Cytyc Corp.’s ThinPrep® monolayer Pap smear test. Pathologists and laboratory directors are noticing two perceived benefits …
Ex-NHL Executives Buy American Medical Labs
By Robert Michel | From the Volume IV No. 7 – May 12, 1997 Issue
CEO SUMMARY: American Medical Laboratories’ sale to new owners is a major event. Not only does the new management team have a reputation for top performance in selling clinical laboratory services, but they also arrive with an ample war chest. When the revamped AML hits the competitive …
New York Labs Sue State To Overturn Surcharge
By Robert Michel | From the Volume IV No. 3 – February 17, 1997 Issue
CEO SUMMARY: With the new laboratory test surcharge in place since January 1, 1997, clinical laboratories already see negative financial effects. Administration and collection of the tax is a nightmare. Some managed care companies moved swiftly to reduce reimbursement to laboratories in o…
Three Public Laboratories Choose New Presidents
By Robert Michel | From the Volume IV No. 2 – January 27, 1997 Issue
CEO SUMMARY: Three public laboratories experiencing serious financial pressure enter the new year with a change in presidents. It is a sign that stockholders and creditors are growing increasingly restless with these organizations’ inability to earn satisfactory profits. …
CURRENT ISSUE

Volume XXXII, No. 6 – April 21, 2025
Now that a federal judge has vacated the FDA’s LDT rule, The Dark Report analyzes the judgement and notes the various steps the FDA could take in response. Also, lab testing at pharmacies is proving to be less successful than was once anticipated.
See the full table of contentsHow Much Laboratory Business Intelligence Have You Missed?
Lab leaders rely on THE DARK REPORT for actionable intelligence on important developments in the business of laboratory testing. Maximize the money you make-and the money you keep! Best of all, it is released every three weeks!
Sign up for TDR Insider
Join the Dark Intelligence Group FREE and get TDR Insider FREE!
Never miss a single update on the issues that matter to you and your business.
Topics
- Anatomic Pathology
- Clinical Chemistry
- Clinical Laboratory
- Clinical Laboratory Trends
- Digital Pathology
- Genetic Testing
- In Vitro Diagnostics
- IVD/Lab Informatics
- Lab Intelligence
- Lab Marketplace
- Lab Risk & Compliance
- Laboratory Automation
- Laboratory Billing
- Laboratory Compliance
- Laboratory Equipment
- Laboratory Information Systems
- Laboratory Management
- Lean Six Sigma
- Managed Care Contracts
- Molecular Diagnostics
- Pathology Trends
- People
- Uncategorized